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Abstract
Porous and bioactive gelatin–siloxane hybrids were successfully synthesized by using a combined sol–gel processing, post-gelation
soaking, and freeze-drying process to provide a novel kind of materials in the developments and optimization of bone tissue
engineering. The pore sizes of the hybrids can be well controlled by varying the freezing temperature. The scaffolds were soaked in a
simulated body fluid (SBF) up to 14 days to evaluate the in vitro bioactivity. The Ca2+-containing scaffolds showed in vitro
bioactivity as they biomimetically deposited apatite, but the Ca2+-free scaffolds failed. Cytotoxicity and cytocompatibility of those
scaffolds and their extracts were monitored by the MC3T3-E1 cell responses, including the cell proliferation and the alkaline
phosphatase activity. It was demonstrated that appropriate incorporation of Ca2+ ions stimulated osteoblast proliferation and
differentiation in vitro. r 2002 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Novel strategies for regenerating diseased or damaged
bone tissue are necessary because of limitations in
conventional therapies for the treatment of trauma,
congenital defect, cancer, and other bone disease. Tissue
engineering approach to repair and regeneration is
founded upon the use of polymer scaffolds, which may
manipulate bone cell functions, encourage migration of
bone cells from border areas to the defect site, and
provide a source of inductive factors to support bone
cell differentiation [1]. The choice of the scaffold
materials is one of the key factors for successful tissue
engineering approaches in bone tissue remedy [2]. Most
of the current researches have been headed toward the
utilization of biodegradable scaffolds that act as
biocompatible conduits for bone repair or regeneration
[2,3]. Extensively explored were those derived from
natural biodegradable polymers such as collagen,
gelatin, fibrin, and alginates, or synthetic biodegradable
polymers such as polyglycolide, polylactides, and
copolymers of glycolide with lactides [2–6].
Developing new bone-substitute materials has been
conducted on the basis of that growth of a bonelike
apatite layer on a biomaterial surface can enhance
osteoconductivity [7]. It is proposed that conduction of
osteogenic cells into various porous chitosan scaffolds
[5] was also favored by such apatite deposition. The
formation of such bone-like apatite is favored by
the cooperative behavior of a hydrated silica gel surface
(Si–OH groups) as well as calcium ions to be released
into the body fluid when implanted [8–9]. Thus, hybrid
materials derived from the integration of biodegradable
polymers with the bioactive inorganic species, i.e.,
silanol groups and calcium ions may construct a new
group of scaffolds appropriate for tissue engineering.
In the previous work [10], we synthesized a novel
group of gelatin–siloxane hybrids derived from the
integration of gelatin and 3-(glycidoxypropyl) tri-
methoxysilane (GPSM). The results showed that the
GPSM molecules bridged the gelatin chains, the amount
of the bridging bonds or cross-link density controlled
the rate of degradation of the gelatin component in the
hybrids, and the gelatin–siloxane hybrids displayed
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obvious bioactivity due to incorporation of Ca2+ ions
[11]. Moreover, the freeze-drying technique was intro-
duced for preparing the porous hybrids [12]. In this
paper, we report a novel method for the fabrication of
porous Ca2+-containing gelatin–siloxane hybrids by a
combined sol–gel processing, post-gelation soaking
process, and freeze-drying. The effects of compositions
and synthesis conditions on the pore structures, the in
vitro bioactivity, and the in vitro of cytocompatibilty of
the hybrid scaffolds are described in details.
2. Materials and methods
2.1. Preparation of gelatin–siloxane hybrid scaffolds
GPSM was purchased from CHISSO CO. (Tokyo,
Japan), while all other reagents were obtained from
NACALAI TESQUE INC. (Kyoto, Japan). Reagent
grade chemicals were used as the starting materials
without further treatments. The gels were prepared as
described previously [10–12]. In brief, a 12.5 mass%
solution was first prepared by dissolving gelatin in a
0.1m HCl aqueous solution. Addition of appropriate
amount of GPSM and Ca(NO3)2 to the gelatin solution
resulted in the hybrid sols, to which gelling treatment
was subsequently applied [11,12]. The composition was
expressed as the mass fractions of fG and fCa,
respectively defined by
fG ¼ GPSM=ðGPSMþ gelatinÞ; ð1Þ
fCa ¼ CaðNO3Þ2=ðCaðNO3Þ2 þGPSMþ gelatinÞ: ð2Þ
The porous hybrid scaffolds (denoted as scaffolds)
were obtained by post-gelation soaking and a subse-
quent freeze-drying. Namely, the gelatin–siloxane hy-
brid gels were soaked in a 1m NH4OH solution for 16 h,
and were subsequently kept in freezing baths maintained
at 171C, 801C, or 1961C. The frozen hybrids were
finally lyophilized in a freeze-dryer (FDU-506, EYELA)
for 2 days to complete dryness. Some of the porous gels
frozen at 171C were again soaked in 1m NH4OH for
additional 16 h and subsequently subject to the second
freezing at 1961C and drying. Such additional soaking
and freeze-drying introduced a bimodal-pore distribu-
tion. The morphology of the scaffolds was observed by a
scanning electron microscope (SEM, JEOL JSM-6300)
at acceleration voltage of 20 kV after coating a 30 nm
Au film. The porosity was measured by the Archimedes
principle, while the pore size was derived from SEM
photographs of fracture surfaces.
2.2. In vitro bioactivity
The scaffolds 10 10 2mm3 in size were soaked in
35ml of a simulated body fluid (SBF, Kokubo solution
[13–15]) similar in ionic composition to the human
blood plasma. It was buffered at pH 7.40 with 50mm
Tris and 45mm HCl. The temperature was kept at
36.51C throughout the incubation period. It has been
confirmed that this fluid can well reproduce in vivo
reactions like the apatite formation under an in vitro
experiment [8–9,13–15]. After having soaked for pre-
determined periods, the scaffolds were removed from
the fluid and gently rinsed with distilled water. Apatite
formation on the surface of the specimens was examined
with thin-film X-ray diffraction (TF-XRD, RAD-II,
Rigaku, CuKa, 40kV, 20mA) with an angle of 11 to the
direction of the incident X-ray. The specimen surfaces
were also subject to SEM observation.
2.3. Cytotoxicity test of scaffold extracts
Osteoblast-like cells (MC3T3-E1) were supplied by
Dr. Sumita in National Research Institute for Metal,
Japan. Prior to the cell culture test, 4 g of each scaffold
was kept in a capped polystyrene flask with 20ml of
distilled water and placed in an incubator at 36.51C for
120 h. After having taken out of the incubator and
cooled to 251C, the extract liquid was decanted into a
dry polystyrene bottle. In order to examine cytotoxicity
of the extract, an appropriate amount of a-minimal
essential medium (a-MEM) was dissolved into each
extract, instead of distilled water, to prepare the a-MEM
medium. The obtained extract-containing a-MEM was
subsequently filtered using 0.2 mm sieves for sterilization.
Both 20 ml of the prepared cell suspension
(5 105 cells/ml) and 0.98ml of the sterilized extract-
containing a-MEM were put into 24-well culture plate
and mixed, so that the cell concentration in each well
was attained to 1.0 104 cells/ml. The cells were
cultured up to 7 days at 371C under an atmosphere of
5% CO2 and 95% humidity. They were also cultured in
common a-MEM media under the same conditions as
above, and denoted as blank. For evaluation of cell
proliferation, the cells were removed from 24-well
culture plates by adding a 0.1m phosphate-buffered
aqueous solution (pH 7.4) containing 0.01wt% actinase
E and 0.02wt% EDTA-2Na at 371C for 3min. After
centrifuging the solution, the cells were suspended in a-
MEM, and the number of the removed cells was
measured with hemocytometer. Alkaline phosphatase
(ALP) activity of the cultured cells was also measured.
After being rinsed with the 0.1m phosphate-buffer
solution and a 50mm Tris-HCl buffer solution (pH
7.45), the cells were incubated at 371C in 100 ml of a
solution that consisted of 2mm Na2-nitrophenylpho-
sphate and 2mm MgCl2 in a 0.1m 2-amino-2-methyl-1-
propanol buffer (pH 10.5). After incubation for 24 h,
100 ml of 1n NaOH was added to stop hydrolysis of
p-nitrophenylphosphate in the cells under being cata-
lyzed by alkaline phosphatase. The ALP activity was
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subsequently evaluated by measuring optical adsorption
at 405 nm with a micro plate reader (Immunmin NJ-
2300, Intermed). Triplicate culture experiments were
performed and the results were described as arithmetic
means7standard deviation (SD). Unpaired, two-tailed
ttests were performed at each time point to detect the
presence of any significant difference in number and
ALP activity of the MC3T3-E1 cells cultured with
extracts versus that for the blank.
2.4. In vitro cell culture on scaffolds
Prior to being employed in the cell culture test,
scaffolds of 10 10 2mm3 in size were sterilized in an
autoclave at 1201C, 0.17MPa, with a 20-min pressure
cycle. The sterilized scaffolds were then respectively
placed in each well of a 24-well culture plate, and were
pre-wetted with 1ml of a-MEM for 1 day. Then, the
medium in each well was exchanged with 1ml of
a-MEM containing 1.0 104MC3T3-E1 cells. The cells
on each scaffold after culturing were fixed by soaking in
a 0.1m phosphate-buffer (PB, pH 7.40) solution contain-
ing 2% glutaraldehyde for 2 h at 41C. After being
dehydrated with the graded ethanol–water solutions of
50% to 100% for 15min and 100% 3-butanol 3 times
for 30min at each step, the scaffolds were freeze-dried at
13.3 Pa (0.1 Torr) and 51C. Finally, the scaffold
surface was subject to SEM observation, at an accel-
erating voltage of 10 kV.
3. Results
3.1. Effects of the freezing temperature on pore structure
The porous hybrid scaffolds were fabricated by
freezing the swollen bulk hybrids and subsequently
lyophilizing the frozen structures. Fig. 1 demonstrates
that those scaffolds could be easily shaped into
3-dimensional scaffolds of any shape, such as orthor-
hombic, cubic, plate, or cylindrical ones. Table 1
summarizes the pore characteristics of all 3-dimensional
porous hybrids obtained. The density of the scaffolds
increased with fG; while pore size, porosity, and open
porosity decreased with fG: Freezing temperature (Tf )
affected the pore size and porosity (total and open) as
later illustrated in Fig. 2. In contrast, Ca2+-incorpora-
tion had little effect on the pore structure. Fig. 2 shows
the fracture surface of scaffolds I (Tf ¼ 171C), II
(Tf ¼ 801C), and III (Tf ¼ 1961C), respectively. The
results showed that the higher the freezing temperature
Tf was, the larger the pore size was; Namely hybrids I,
II, and III had 300–500 mm, 30–50 mm, and 5–10 mm in
pore diameter, respectively. Therefore, it is evident that
the pore size of the hybrids could be controlled in the
range from a few mm to several hundreds mm, by varying
the freezing temperature. The fact that the fast freezing
at –1961C produced smaller pores than the slow freezing
process at –171C can be interpreted by the faster rate of
nucleation and generation of more ice nuclei due to the
greater super-cooling effect.
The most significant characteristic of the scaffolds
I–A and I*–A in Table 1 is the bimodal-pore distribu-
tion. Fig. 3 shows a typical fracture surface of scaffold
I*–A, which had the smaller pores with 5–10 mm in
diameter and the larger ones with 300–500 mm. Such
morphology is quite different from that for the scaffolds
I and I*, without the secondly treatment. Table 1 also
indicates that the secondly treatment increased the total
and open porosity with the values of SD taken into
consideration.
3.2. In vitro apatite deposition
Figs. 4a and b show the TF-XRD patterns for
scaffolds I* and I after soaking in SBF for up to 14
days. The diffractions for as-prepared scaffolds were
denoted as ‘‘0d’’. Scaffold I* showed XRD peaks
assignable to apatite [13], while scaffold I did not. The
sharper TF-XRD peak at 26.01 has been ascribed to
the (0 0 2) diffraction, and a broader one at about 32.01
to an envelope of (2 1 1), (1 1 2) and (3 0 0) diffractions
[11–15]. The fact that no other scaffolds than containing
Ca2+ ions could deposit apatite indicates that incor-
poration of Ca2+ ions is essential to provide hybrids
with the in vitro bioactivity.
Fig. 5 shows the SEM photographs of the cross
sections of scaffolds I* and I*–A after soaking in SBF
for 3 days. Fig. 5a indicates that apatite particles covered
the whole inner wall of the primary pores of scaffold I*
in 3 days, and the morphology of the deposited apatite
Fig. 1. The as-prepared gelatin–siloxane hybrid scaffold I* (fG ¼ 0:50;
fCa ¼ 0:11; Tf ¼ 171C). The diameter of the coin on the right-hand
side is exact 20mm.
L. Ren et al. / Biomaterials 23 (2002) 4765–4773 4767
was semi-spherical agglomerates consisting of flake-like
crystallites (Fig. 5b), similar to that deposited in vitro on
Ca2+-containing bulk hybrids and other bioactive
materials [13–15]. Fig. 5c shows that after soaking in
SBF for 3 days, the small pores of scaffold I*–A were
filled with apatite and looked like solid.
Fig. 2. The fracture surface of scaffolds (a) I (Tf ¼ 171C), (b) II (Tf ¼ 801C), and (c) III (Tf ¼ 1961C). Hybrids I, II, and III have the same
composition (fG ¼ 0:50; fCa ¼ 0).
Table 1
Preparation, density, pore characteristics, and in vitro bioactivity of the gelatin–siloxane hybrid scaffolds















I 0.50 0 17 None 0.30970.031 80.972.7 66.774.1 300–500 —
I* 0.50 0.11 17 None 0.31570.041 81.774.9 68.174.7 300–500 o1
II 0.50 0 80 None 0.58970.033 62.374.2 36.273.0 30–50 —
II* 0.50 0.11 80 None 0.56870.042 65.877.1 38.474.2 30–50 o1
III 0.50 0 196 None 0.71270.053 47.176.1 20.871.9 5–10 —
III* 0.50 0.11 196 None 0.71970.027 49.972.6 21.673.7 5–10 o1
IV 0.33 0 17 None 0.23470.045 84.774.6 75.273.8 500–700 —
V 0.67 0 17 None 0.48470.059 76.975.7 48.574.3 200–300 —
I–A 0.50 0 17 196 0.26470.038 94.374.1 69.976.9 300–500 & 5–10 —
I*–A 0.50 0.11 17 196 0.26870.035 95.373.2 72.974.6 300–500 & 5–10 o1
aFreezing temperature.
bDerived from Archimede method, n ¼ 5 for standard deviation. e: Total porosity; eo: Open porosity.
cDerived from SEM observation.
d Induction period for apatite deposition (day).
e fG=GPSM/(GPSM+Gelatin).
f fCa=Ca(NO3)2/(Ca(NO3)2+GPSM+Gelatin).
—: No apatite deposition.
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3.3. Indirect assay of cytocompatibility
Figs. 6a and b, respectively show the effects of GPSM
content (fG) on the proliferation and ALP activity
profiles for the MC3T3-E1 cells as they were cultured
with the extracts of scaffolds. Fig. 6a indicates no
significant difference among the proliferation of cells
in the extracts of IV (fG ¼ 0:33; fCa ¼ 0), I (fG ¼ 0:50;
fCa ¼ 0), and blank by day 7 (p > 0:05). However, after 3
days culture, the cells were less in number in extract V
(fG ¼ 0:67; fCa ¼ 0) than blank (po0:05). Fig. 6b shows
that the ALP activity of the MC3T3-E1 cells cultured in
all extracts increased with the culture time. The cells
showed larger ALP activity when cultured in the
medium with extracts IV and I until days 5 (po0:05)
than blank. Addition of extract V caused little effects on
the activity until day 5 but while it decreased after day 5
(po0:05). Figs. 7a and b demonstrate the effects of the
extracts on the proliferation and ALP activity of the
MC3T3-E1 cells as a function of fCa: It is indicated that
both were favored by addition of extracts I* and I*–A
(fCa ¼ 0:11). Moreover, the ALP activity profiles for
both extracts I* and I*–A showed peaks at day 5 of
culture.
3.4. SEM observation of cell proliferation (or culture) in
scaffolds
Cellular behavior on the scaffolds is an important
factor in evaluating their biocompatibility. Figs. 8a
through e are the SEM photographs of the MC3T3-E1
cells cultured on Ca2+-containing scaffold I*
(fCa ¼ 0:11) up to 3 weeks. Fig. 8a reveals that the cells
attached on the surfaces after culture for 1 day and
extended filopodia. Fig. 8b presents a typical polygonal
morphology characteristic of osteoblast in vitro cultured
for 7 days. It follows that the MC3T3-E1 cells had
begun to form an interconnecting network within a
week. Fig. 8c indicates that a confluent cell multilayer
covered the whole scaffold surface after 2 weeks of
culture. Moreover, one can see in Fig. 8d that 2-weeks
culture resulted in nodular morphology for MC3T3-E1
cells, and that the surface of the cells was covered with a
large number of globules with 0.5–1.0 mm in diameter.
EDS analysis indicated that the globules were rich in Ca.
It is obvious in Fig. 8e that cells processed in addition to
bundles of collagen fibrils after 3 weeks of culture.
Fig. 9 is for Ca2+-free scaffold I after culturing the
MC3T3-E1 cells up to 3 weeks. Fig. 9a shows that after
culture for 1 day, fewer cells attached on scaffold I than
on Ca2+-containing scaffold I* (Fig. 8a). Moreover,
Fig. 9b shows that cells on scaffold I did not yield either
mineralized particles or collagen fibrils even after
the culture for 3 weeks. Thus, the incorporation of
Ca2+ ions in scaffolds evidently enhanced MC3T3-E1
cell proliferation and differentiation.
Figs. 10a–c show MC3T3-E1 cells cultured for up to 3
weeks on scaffold I*–A having a bimodal-pore distribu-
tion. Note in Fig. 10a that the cells grew along the small
pore architecture by day 7. Fig. 10b shows that a
cell multilayer was formed on scaffold I*–A after culture
for 3 weeks. However, its morphology was different
from that formed on scaffold I* as shown in Fig. 8c.
Nevertheless, Fig. 10c indicates cells cultured on scaf-
fold I*–A also yielded such Ca-rich globules and
a network of collagen fibers after culture for 3 week
similar to those previously found in Fig. 8e for
scaffold I*.
4. Discussion
The strong increase in bone tissue engineering
research has accentuated the need for a new class of
Fig. 3. The fracture surface of scaffold I*–A (fG ¼ 0:50; fCa ¼ 0:11)
with a bimodal-pore distribution: bigger pores: 300–500mm in
diameter, smaller pores: 5–10mm in diameter.
























Fig. 4. Thin film X-ray diffraction (Cu Ka) patterns of scaffolds (a) I*
(fG ¼ 0:50; fCa ¼ 0:11; Tf ¼ 171C), and (b) I (fG ¼ 0:50; fCa ¼ 0;
Tf ¼ 171C) before and after soaking in SBF up to 14 days. O:
apatite.
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biodegradable porous hybrid materials having the
potential of a specific and controllable bioactivity [2].
We developed gelatin–siloxane hybrids derived from the
integration of biodegradable natural polymer with
bioactive inorganic species to construct a new group of
scaffolds appropriate for tissue engineering. Firstly, the
present scaffold materials are designed to be porous and
permeable to allow for the ingress of nutrients and
removal of waste products, and to allow for the
ingrowth of vascular tissue to ensure the survival of
the transplanted cells. The present scaffold materials are
also designed to be biodegradable [12], allowing for the
defect tissues to grow and to occupy the space voided as
the scaffold materials are degraded. Equally important,
the present scaffold materials are designed to directly to
living bone without formation of the fibrous tissues,
Fig. 5. (a) Apatite formed on the pore walls of hybrid I* (fG ¼ 0:50; fCa ¼ 0:11; Tf ¼ 171C) after soaking in SBF up for 3 days, (b) high
magnification of (a): the deposited apatite is of spherical agglomerate of flake-like crystallizes, and (c) the fracture surface of hybrid I*–A (fG ¼ 0:50;
fCa ¼ 0:11; Tf ¼ 171C and 801C, with a bimodal-pore distribution) after soaking in SBF up for 3 days: apatite filled up the smaller pores.









































Fig. 6. (a) Proliferation, and (b) ALP activity of MC3T3-E1 cells
cultured with the extracts of scaffolds I (fG ¼ 0:50; fCa ¼ 0), IV
(fG ¼ 0:33; fCa ¼ 0), and V (fG ¼ 0:67; fCa ¼ 0) as well as blank






































Fig. 7. (a) Proliferation, and (b) ALP activity of MC3T3-E1 cells
cultured with the extracts of scaffolds I* (fG ¼ 0:50; fCa ¼ 0:11; having
300–500mm pores), and I*–A (fG ¼ 0:50; fCa ¼ 0:11; having a bimodal-
pore distribution) as well as blank (without the extract) up to 7 days.
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when they are implanted in the body. The formed
apatite layer may not only prevent the failure of
implantation but also favor the attachment and
proliferation of osteoblast cells [2,8–9].
The present technique of using sol–gel method
and freeze-drying not only yields porous hybrids
of any shape, but also takes advantage of avoiding
organic solvents that may be toxic to human. The
Ca2+-containing porous hybrids with relatively uniform
in pore size of several hundred mm find applications in
bony tissues because the range of the pore size attained
in the present study has been demonstrated to be
optimal for bone tissue regeneration [2,16]. Scaffolds
having several mm pores may also be used for controlled
release of drug or other biological factor [17–18]. One of
the interesting characteristics of the porous hybrids
presented here is the bimodal-pore architecture. The
macroporous architecture may provide not only chan-
nels for improving mass transport and neo-vasculariza-
tion after being implanted in vivo, but also better
environment for cell distribution, adhesion, growth, and
differentiated function. Moreover, the micro pores are
expected to control the release of the incorporated drug
or biological factor to favor tissue repairing. Thus, the
Fig. 8. The SEM photographs of MC3T3-E1 cells cultured on scaffold I* (fG ¼ 0:50; fCa ¼ 0:11) for (a) 1 day, (b) 1 week, (c) & (d) 2 weeks, and (e) 3
weeks. It is indicated that the cell surface was covered with a large number of Ca-rich globules with 0.5–1.0mm in diameter on (d), and cells processed
in addition to bundles of collagen fibrils after 3 weeks of culture (e).
Fig. 9. The SEM photographs of MC3T3-E1 cells cultured on scaffold I (fG ¼ 0:50; fCa ¼ 0) for (a) 1 day, (b) 3 week. No mineralized particles or
collagen fibrils were found.
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architectural design at a bimodal-pore distribution gives
these novel porous hybrids the potential to be tailored
into ideal porous hybrids for bone tissue engineering.
The in vitro bioactivity is the most exciting character-
istic of the present Ca2+-containing porous hybrids. The
incorporation of Ca2+ ions is found to be a key factor to
provide the porous hybrids with bioactivity in vitro. A
number of studies on bioactive ceramics have indicated
that in vivo formation of Ca–P-rich layer and surface
bone-like apatite is a key step for formation of direct
bond between bone and these materials, and that SBF
well reproduces in vivo reaction of the materials [8,9].
Thus, the present Ca2+-containing porous hybrids may
also show bioactivity in vivo, and may directly bond to
the surrounding osseous tissue.
The present study employed osteoblast cell line
MC3T3-E1 since those cells resemble osteogenic cells
in vivo in many ways [19–20]. Here, the cytotoxicity and
cytocompatibility of the scaffolds were evaluated by
examining MC3T3-E1 cell responses to the extracts
obtained by soaking them in the culture medium.
MC3T3-E1 cell function was monitored by ALP
activity, since it is a common indicator of the expression
of osteoblastic phenotype [21–23]. The evaluation of the
cell responses to the scaffold extracts may provide a
more clear indication of possibly toxic effects of any
ions released by the scaffolds themselves, by-passing the
additional complication of surface-associated modula-
tion of cell proliferation and function [24]. The present
results showed that the presence of extracts I; I*, and IV
slightly stimulated the proliferation of MC3T3-E1 cells.
ALP activity of MC3T3-E1 cells was dramatically
promoted by addition of extract I* and I*–A to the
culture medium (or a-MEM), suggesting that the
increase of Ca2+ ions in the media played an important
role in the expression of the osteoblastic phenotype in
MC3T3-E1 cells. The results described above thus
concluded that Ca2+-containing scaffolds I* and I*–A
(fCa ¼ 0:11) are cytocompatible, and simulate osteogenic
proliferation and differentiation of the MC3T3-E1 cells.
In order to examine the possible use of these scaffolds
in bone tissue engineering, MC3T3-E1cells were also
seeded into hybrid scaffolds to study the cell-biomaterial
interactions. SEM observation revealed that MC3T3-E1
cells growing on Ca2+-containing scaffold I* and I*–A
retained their characteristic polygonal morphology,
Fig. 10. The SEM photographs of MC3T3-E1 cells cultured on scaffold I*–A having a bimodal-pore distribution for (a) 1 week, (b) 3 weeks, and (c)
is high magnification of (b), indicating the formation of Ca-rich globules and collagen fibers.
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suggesting that scaffolds I* and I*–A are suitable for
osteoblast growth. However, the difference between
Figs. 8 and 10 pointed out that the surface morphology
might influence cell response, which need to be
investigated further.
5. Conclusions
Porous gelatin–siloxane hybrids were prepared by
using a combined sol–gel processing, post-gelation
soaking, and freeze-drying process. The freezing tem-
perature controlled pore size. A secondly soaking of the
porous hybrids resulted in a bimodal-pore distribution.
The Ca2+-containing porous hybrids showed in vitro
bioactivity as they biomimetically deposited apatite. The
Ca2+-containing scaffolds may find application to bony
tissues. The hybrids with several mm pores may also be
used for controlled drug/biological factors delivery.
Finally, the scaffolds with bimodal pores may be useful
for the combinations of the above. MC3T3-E1 cell
culture was used to evaluate the potential of scaffolds
for bone tissue engineering. It is demonstrated that the
appropriate incorporation of Ca2+ ions stimulated
osteoblast proliferation and differentiation in vitro.
Ca2+-containing scaffolds I* and I*–A are expected to
be suitable substrates for osteoblast growth and
differentiated function. Hence, the porous gelatin–
siloxane hybrids described above may provide one kind
of the basic materials in the developments and
optimization for a variety of tissue scaffolds and
regeneration aids.
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